scholarly journals Targeting DNA Methyltransferase 1 Limits Vesicular Stomatitis Virus Through Enhancing IRF3/IFN Signaling

2020 ◽  
Author(s):  
Kui Zhao ◽  
Fei Gao ◽  
Ye Lin ◽  
Jing Lin ◽  
Bo Zhang ◽  
...  

Abstract BackgroundViruses develop strategies to escape from host anti-viral response in many aspects including hijacking host epigenetic factors. However, the relationship between host DNA methyltransferase 1 (DNMT1) and vesicular stomatitis virus (VSV) replication is largely unknown.MethodsIn the present study, we performed Western Blotting, qRT-PCR, RNA interference, Methylation-specific PCR and Cell viability assay to uncover the role of DNMT1 in the process of VSV replication.ResultsWe have observed VSV infection enhances DNMT1 protein accumulation in macrophage cell. Furthermore, DNMT1 functional blocking and gene silencing limit VSV replication. Moreover, loss of DNMT1 increases interferon responses, including Ifnb1 and IFN-stimulated genes (ISGs) upregulation. CpG islands (CGIs) of Irf3 promoter region are demethylated after DNMT1 short-term inhibition with thioguanine, which is accompanied by Irf3 transcript upregulation. Meanwhile, Irf3 silencing largely reversed DNMT1 loss-suppressed VSV replication. What is more, the basal level of endogenous retrovirus (ERV) transcripts is required for thioguanine-induced ISGs.ConclusionsDNMT1 loss-induced IRF3 enhancement leads to interferon responses and subsequent VSV suppression, which provides a potential strategy to inhibit viral replication by targeting DNMT1 with its inhibitor.

2021 ◽  
Vol 22 ◽  
Author(s):  
Pooja Yadav ◽  
Shreetama Bandyopadhayaya ◽  
Bridget M Ford ◽  
Chandi Mandal

Cancer is a genetic disease resulting from genomic changes, however epigenetic alterations act synergistically with these changes during tumorigenesis and cancer progression. Epigenetic variations are gaining more attraction as an important regulator in tumor progression, metastasis and therapy resistance. Aberrant DNA methylation at CpG islands is a central event in epigenetic-mediated gene silencing of various tumor suppressor genes. DNA methyltransferase 1 (DNMT1) predominately methylates at CpG islands on hemimethylated DNA substrates in proliferating cells. DNMT1 has been shown to be overexpressed in various cancer types and exhibits tumor-promoting potential. The major drawbacks to DNMT1-targeted cancer therapy are the adverse effects arising from nucleoside and non-nucleoside based DNMT1 inhibitors. This paper focuses on the regulation of DNMT1 by various microRNAs (miRNAs), which may be assigned as future DNMT1 modulators, and highlights how DNMT1 regulates various miRNAs involved in tumor suppression. Importantly, the role of reciprocal inhibition between DNMT1 and certain miRNAs in tumorigenic potential is approached with this review. Hence, this review seeks to project an efficient and strategic approach using certain miRNAs in conjunction with conventional DNMT1 inhibitors as a novel cancer therapy. It has also pinpointed to select miRNA candidates associated with DNMT1 regulation that may not only serve as potential biomarkers for cancer diagnosis and prognosis, but may also predict the existence of aberrant methylation activity in cancer cells.


2011 ◽  
Vol 108 (9) ◽  
pp. 3630-3635 ◽  
Author(s):  
Lisa S. Shock ◽  
Prashant V. Thakkar ◽  
Erica J. Peterson ◽  
Richard G. Moran ◽  
Shirley M. Taylor

Epigenetics ◽  
2013 ◽  
Vol 8 (9) ◽  
pp. 944-952 ◽  
Author(s):  
Bernardo J Krause ◽  
Paula M Costello ◽  
Ernesto Muñoz-Urrutia ◽  
Karen A Lillycrop ◽  
Mark A Hanson ◽  
...  

2016 ◽  
Vol 36 (22) ◽  
pp. 6050-6068 ◽  
Author(s):  
Hirofumi Noguchi ◽  
Naoya Murao ◽  
Ayaka Kimura ◽  
Taito Matsuda ◽  
Masakazu Namihira ◽  
...  

Biochimie ◽  
2014 ◽  
Vol 106 ◽  
pp. 149-156 ◽  
Author(s):  
Cheng-gui Miao ◽  
Ying-ying Yang ◽  
Xu He ◽  
Cheng Huang ◽  
Yan Huang ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document